Vjera A Holthoff

Summary

Country: Germany

Publications

  1. ncbi Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study
    Vjera Holthoff
    DZNE, German Center for Neurodegenerative Diseases, Dresden, and University Hospital Carl Gustav Carus, University of Technology, Dresden, Germany
    Int J Geriatr Psychiatry 28:164-72. 2013
  2. ncbi [Pharmacotherapy of depression in the elderly]
    V Holthoff
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Deutsches Zentrum für Neurodegenerative Erkrankungen, Partnerstandort Dresden, Technische Universitat Dresden, Fetscherstr 74, 01307, Dresden, Deutschland
    Z Gerontol Geriatr 46:112-9. 2013
  3. ncbi Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice
    Vjera A Holthoff
    Old Age Psychiatry and Cognitive Neuropsychiatry, University Hospital Carl Gustav Carus, University of Technology, Fetscherstraße 74, Dresden 01307, Germany
    Alzheimers Res Ther 3:27. 2011

Detail Information

Publications3

  1. ncbi Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study
    Vjera Holthoff
    DZNE, German Center for Neurodegenerative Diseases, Dresden, and University Hospital Carl Gustav Carus, University of Technology, Dresden, Germany
    Int J Geriatr Psychiatry 28:164-72. 2013
    ....
  2. ncbi [Pharmacotherapy of depression in the elderly]
    V Holthoff
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Deutsches Zentrum für Neurodegenerative Erkrankungen, Partnerstandort Dresden, Technische Universitat Dresden, Fetscherstr 74, 01307, Dresden, Deutschland
    Z Gerontol Geriatr 46:112-9. 2013
    ..Lithium augmentation has been shown to be effective in treatment-refractory depression. Continuation therapy is recommended for at least 9 months and duration of maintenance therapy should be at least 2 years...
  3. ncbi Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice
    Vjera A Holthoff
    Old Age Psychiatry and Cognitive Neuropsychiatry, University Hospital Carl Gustav Carus, University of Technology, Fetscherstraße 74, Dresden 01307, Germany
    Alzheimers Res Ther 3:27. 2011
    ..The validity and reliability of ROSA as well as sensitivity to changes due to intervention were examined in an open-label, single-arm, multicenter clinical study in patients with Alzheimer's disease (AD)...